NCT00316147View on ClinicalTrials.gov

Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

August 31, 2006

Conditions
DiphtheriaAcellular PertussisTetanusHaemophilus Influenzae Type bHepatitis BPoliomyelitis
Interventions
BIOLOGICAL

DTPa-HBV-IPV/Hib vaccine

Trial Locations (4)

110002

GSK Investigational Site, New Delhi

403202

GSK Investigational Site, Goa

560034

GSK Investigational Site, Bangalore

390 001

GSK Investigational Site, Baroda

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY